LYEL - Lyell Immunopharma Inc. Looks to Continue to Trade Above its Annual-High Share Price Today
Lyell Immunopharma Inc. (NASDAQ:LYEL) traded at a new 52-week high today of $19.75. This new high was reached on approximately average trading volume as 221,000 shares traded hands, while the average 30-day volume is approximately 201,000 shares.
Lyell Immunopharma Inc is a T cell reprogramming company dedicated towards the mastery of T cells to eradicate solid tumors.
In the past 52 weeks, shares of Lyell Immunopharma Inc. have traded between a low of $13.11 and a high of $19.75 and is now at $17.01, which is 30% above that low price.
Based on a current price of $17.01, Lyell Immunopharma Inc. is currently 76.8% above its average consensus analyst price target of $3.95.
Receive IBN Spotlights - "Bite Size" Small, Mid and Large-Cap Technical Indicator Alerts
To stay connected with our complimentary IBN Spotlights, please visit https://IBN.fm/connected
About InvestorBrandNetwork (IBN)
InvestorBrandNetwork (IBN) consists of 50+ trusted financial brands introduced to the investment public over the course of 15+ years. Through these brands, IBN provides (1) access to our Investor Press Release Wire Solutions via InvestorWire (IW) to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions via IW to ensure maximum impact; (4) full-scale distribution to an enormous social media audience that includes millions of followers; and (5) a full array of corporate communications solutions focused on the IBN Podcast Series. With a proven track record serving 500+ client partners, IBN is the key to a more effective market communication campaign.
For more information, please visit https://www.InvestorBrandNetwork.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer